FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:295-303 January 23, 2003 Number 4 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background The influence of left ventricular outflow tract obstruction on the clinical outcome of hypertrophic cardiomyopathy remains unresolved.

Methods We assessed the effect of outflow tract obstruction on morbidity and mortality in a large cohort of patients with hypertrophic cardiomyopathy who were followed for a mean (±SD) of 6.3±6.2 years.

Results Of the 1101 consecutive patients, 273 (25 percent) had obstruction of left ventricular outflow under basal (resting) conditions with a peak instantaneous gradient of at least 30 mm Hg. A total of 127 patients (12 percent) died of hypertrophic cardiomyopathy, and 216 surviving patients (20 percent) had severe, disabling symptoms of progressive heart failure (New York Heart Association [NYHA] functional class III or IV). The overall probability of death related to hypertrophic cardiomyopathy was significantly greater among patients with outflow tract obstruction than among those without obstruction (relative risk, 2.0; P=0.001). The risk of progression to NYHA class III or IV or death specifically from heart failure or stroke was also greater among patients with obstruction (relative risk, 4.4; P<0.001), particularly among patients 40 years of age or older (P<0.001). Age-adjusted multivariate analysis confirmed that outflow tract obstruction was independently associated with an increased risk of both death related to hypertrophic cardiomyopathy (relative risk, 1.6; P=0.02) and progression to NYHA class III or IV or death from heart failure or stroke (relative risk, 2.7; P<0.001). The likelihood of severe symptoms and death related to outflow tract obstruction did not increase as the gradient increased above the threshold of 30 mm Hg.

Conclusions In patients with hypertrophic cardiomyopathy, left ventricular outflow tract obstruction at rest is a strong, independent predictor of progression to severe symptoms of heart failure and of death.

Source Information

From the Division of Cardiology, Tufts–New England Medical Center, Boston (M.S.M.); the Regional Referral Center for Myocardial Diseases, Azienda Ospedaliera Careggi, Florence, Italy (I.O., F.C.); the Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Federico II University of Naples, Naples, Italy (S.B., M.A.L.); and the Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis (S.A.C., J.R.L., B.J.M.).

Address reprint requests to Dr. Barry Maron at the Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E. 28th St., Suite 60, Minneapolis, MN 55407, or at hcm.maron{at}mhif.org.

Full Text of this Article

Related Letters:

Hypertrophic Cardiomyopathy and Outflow Tract Obstruction
Monserrat L., Penas-Lado M., Castro-Beiras A., Iqbal K., Tramboo N. A., Mohi-Ud-Din K., Spevack D. M., Maron M. S., Olivotto I., Maron B. J.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:1815-1816, May 1, 2003. Correspondence

This article has been cited by other articles:

• Williams, L.K., Frenneaux, M.P., Steeds, R.P. (2009). Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management. Eur J Echocardiogr 10: iii9-iii14 [Abstract] [Full Text]  
• Haruki, S., Minami, Y., Kajimoto, K., Yashiro, B., Suzuki, T., Kawana, M., Hagiwara, N. (2009). Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report. Eur J Heart Fail 0: hfp166v1-hfp166 [Abstract] [Full Text]  
• Ostman-Smith, I., Wisten, A., Nylander, E., Bratt, E.-L., de-Wahl Granelli, A., Oulhaj, A., Ljungstrom, E. (2009). Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy. Eur Heart J 0: ehp443v1-ehp443 [Abstract] [Full Text]  
• Gimeno, J. R., Tome-Esteban, M., Lofiego, C., Hurtado, J., Pantazis, A., Mist, B., Lambiase, P., McKenna, W. J., Elliott, P. M. (2009). Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Eur Heart J 30: 2599-2605 [Abstract] [Full Text]  
• Kwon, D H, Smedira, N G, Popovic, Z B, Lytle, B W, Setser, R M, Thamilarasan, M, Schoenhagen, P, Flamm, S D, Lever, H M, Desai, M Y (2009). Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging. Heart 95: 1784-1791 [Abstract] [Full Text]  
• Wang, J., Buergler, J. M., Veerasamy, K., Ashton, Y. P., Nagueh, S. F. (2009). Delayed untwisting: the mechanistic link between dynamic obstruction and exercise tolerance in patients with hypertrophic obstructive cardiomyopathy.. J Am Coll Cardiol 54: 1326-1334 [Abstract] [Full Text]  
• Myerburg, R. J., Reddy, V., Castellanos, A. (2009). Indications for implantable cardioverter-defibrillators based on evidence and judgment.. J Am Coll Cardiol 54: 747-763 [Abstract] [Full Text]  
• Maron, M. S., Olivotto, I., Maron, B. J., Prasad, S. K., Cecchi, F., Udelson, J. E., Camici, P. G. (2009). The case for myocardial ischemia in hypertrophic cardiomyopathy.. J Am Coll Cardiol 54: 866-875 [Abstract] [Full Text]  
• Maron, B. J., Maron, M. S., Wigle, E. D., Braunwald, E. (2009). The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.. J Am Coll Cardiol 54: 191-200 [Abstract] [Full Text]  
• Sherrid, M. V., Wever-Pinzon, O., Shah, A., Chaudhry, F. A. (2009). Reflections of inflections in hypertrophic cardiomyopathy.. J Am Coll Cardiol 54: 212-219 [Abstract] [Full Text]  
• Maron, M. S., Maron, B. J., Harrigan, C., Buros, J., Gibson, C. M., Olivotto, I., Biller, L., Lesser, J. R., Udelson, J. E., Manning, W. J., Appelbaum, E. (2009). Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.. J Am Coll Cardiol 54: 220-228 [Abstract] [Full Text]  
• Sorajja, P., Nishimura, R. A., Gersh, B. J., Dearani, J. A., Hodge, D. O., Wiste, H. J., Ommen, S. R. (2009). Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study.. J Am Coll Cardiol 54: 234-241 [Abstract] [Full Text]  
• Kwon, D. H., Smedira, N. G., Rodriguez, E. R., Tan, C., Setser, R., Thamilarasan, M., Lytle, B. W., Lever, H. M., Desai, M. Y. (2009). Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia.. J Am Coll Cardiol 54: 242-249 [Abstract] [Full Text]  
• Haghjoo, M., Mohammadzadeh, S., Taherpour, M., Faghfurian, B., Fazelifar, A. F., Alizadeh, A., Rad, M. A., Sadr-Ameli, M. A. (2009). ST-segment depression as a risk factor in hypertrophic cardiomyopathy. Europace 11: 643-649 [Abstract] [Full Text]  
• Spirito, P., Autore, C., Rapezzi, C., Bernabo, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N.A. M., Barilla, C. S., Biagini, E., Quarta, G., Conte, M. R., Bruzzi, P., Maron, B. J. (2009). Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy. Circulation 119: 1703-1710 [Abstract] [Full Text]  
• Shephard, R., Semsarian, C. (2009). Advances in the prevention of sudden cardiac death in the young. Ther Adv Cardiovasc Dis 3: 145-155 [Abstract]  
• Jaber, W A, Yang, E H, Nishimura, R A, Sorajja, P, Rihal, C S, Elesber, A, Eeckhout, E, Lerman, A (2009). Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Heart 95: 564-569 [Abstract] [Full Text]  
• Dhar, S. K., Varadharajan, V., Al-Mohammad, A., Sandoval, J., Grech, E. D (2009). Symptomatic hypertrophic obstructive cardiomyopathy: semi-supine bicycle ergometry as a useful provocative manoeuvre to elicit latent gradient. BMJ Case Reports 2009: bcr1020081044-bcr1020081044 [Abstract] [Full Text]  
• Paraskevaidis, I A, Panou, F, Papadopoulos, C, Farmakis, D, Parissis, J, Ikonomidis, I, Rigopoulos, A, Iliodromitis, E K, Th Kremastinos, D (2009). Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensional strain study. Heart 95: 483-489 [Abstract] [Full Text]  
• Siswanto, B B, Aryani, R (2009). Recent advances in diagnosis and management of hypertrophic cardiomyopathy. Heart Asia 2009: 1-4 [Abstract] [Full Text]  
• Soor, G S, Luk, A, Ahn, E, Abraham, J R, Woo, A, Ralph-Edwards, A, Butany, J (2009). Hypertrophic cardiomyopathy: current understanding and treatment objectives. J. Clin. Pathol. 62: 226-235 [Abstract] [Full Text]  
• Olivotto, I., Maron, M. S., Cecchi, F., Maron, B. J. (2009). Reply.. J Am Coll Cardiol 53: 399-399 [Full Text]  
• Cuoco, F. A., Spencer, W. H. III, Fernandes, V. L., Nielsen, C. D., Nagueh, S., Sturdivant, J. L., Leman, R. B., Wharton, J. M., Gold, M. R. (2008). Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy. J Am Coll Cardiol 52: 1718-1723 [Abstract] [Full Text]  
• Afonso, L. C., Bernal, J., Bax, J. J., Abraham, T. P. (2008). Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies.. J Am Coll Cardiol Img 1: 787-800 [Abstract] [Full Text]  
• Malek, L. A., Chojnowska, L., Klopotowski, M., Maczynska, R., Demkow, M., Witkowski, A., Kusmierczyk, B., Piotrowicz, E., Konka, M., Dabrowski, M., Ruzyllo, W. (2008). Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation. Eur J Heart Fail 10: 1123-1126 [Abstract] [Full Text]  
• Maron, M. S., Finley, J. J., Bos, J. M., Hauser, T. H., Manning, W. J., Haas, T. S., Lesser, J. R., Udelson, J. E., Ackerman, M. J., Maron, B. J. (2008). Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy. Circulation 118: 1541-1549 [Abstract] [Full Text]  
• Le Tourneau, T., Susen, S., Caron, C., Millaire, A., Marechaux, S., Polge, A.-S., Vincentelli, A., Mouquet, F., Ennezat, P.-V., Lamblin, N., de Groote, P., Van Belle, E., Deklunder, G., Goudemand, J., Bauters, C., Jude, B. (2008). Functional Impairment of Von Willebrand Factor in Hypertrophic Cardiomyopathy: Relation to Rest and Exercise Obstruction. Circulation 118: 1550-1557 [Abstract] [Full Text]  
• Sorajja, P., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Holmes, D. R. Jr (2008). Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy: An Invasive Hemodynamic Study. J Am Coll Cardiol Intv 1: 552-560 [Abstract] [Full Text]  
• Fernandes, V. L., Nielsen, C., Nagueh, S. F., Herrin, A. E., Slifka, C., Franklin, J., Spencer, W. H. III (2008). Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: The Baylor and Medical University of South Carolina Experience 1996 to 2007. J Am Coll Cardiol Intv 1: 561-570 [Abstract] [Full Text]  
• Murphy, R. T (2008). Bringing the obstruction back into hypertrophic cardiomyopathy. Heart 94: 1249-1250 [Full Text]  
• Kwon, D H, Setser, R M, Thamilarasan, M, Popovic, Z V, Smedira, N G, Schoenhagen, P, Garcia, M J, Lever, H M, Desai, M Y (2008). Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart 94: 1295-1301 [Abstract] [Full Text]  
• Shah, J S, Esteban, M T T, Thaman, R, Sharma, R, Mist, B, Pantazis, A, Ward, D, Kohli, S K, Page, S P, Demetrescu, C, Sevdalis, E, Keren, A, Pellerin, D, McKenna, W J, Elliott, P M (2008). Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart 94: 1288-1294 [Abstract] [Full Text]  
• Steendijk, P, Meliga, E, Valgimigli, M, Ten Cate, F J, Serruys, P W (2008). Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy. Heart 94: 1318-1322 [Abstract] [Full Text]  
• Elliott, P, Spirito, P (2008). Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice. Heart 94: 1269-1275 [Abstract] [Full Text]  
• Ommen, S R, Shah, P M, Tajik, A J (2008). Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future. Heart 94: 1276-1281 [Full Text]  
• Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., Stevenson, W. G., Zipes, D. P. (2008). American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 52: 1179-1199 [Full Text]  
• Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., Stevenson, W. G., Zipes, D. P. (2008). American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 118: 1497-1518 [Full Text]  
• Maron, M. S., Appelbaum, E., Harrigan, C. J., Buros, J., Gibson, C. M., Hanna, C., Lesser, J. R., Udelson, J. E., Manning, W. J., Maron, B. J. (2008). Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy. Circ Heart Fail 1: 184-191 [Abstract] [Full Text]  
• Olivotto, I., Maron, M. S., Autore, C., Lesser, J. R., Rega, L., Casolo, G., De Santis, M., Quarta, G., Nistri, S., Cecchi, F., Salton, C. J., Udelson, J. E., Manning, W. J., Maron, B. J. (2008). Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy. J Am Coll Cardiol 52: 559-566 [Abstract] [Full Text]  
• Kwon, D. H., Kapadia, S. R., Tuzcu, E. M., Halley, C. M., Gorodeski, E. Z., Curtin, R. J., Thamilarasan, M., Smedira, N. G., Lytle, B. W., Lever, H. M., Desai, M. Y. (2008). Long-Term Outcomes in High-Risk Symptomatic Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation. J Am Coll Cardiol Intv 1: 432-438 [Abstract] [Full Text]  
• Sorajja, P., Valeti, U., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., Holmes, D. R. Jr (2008). Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy. Circulation 118: 131-139 [Abstract] [Full Text]  
• Saumarez, R. C., Pytkowski, M., Sterlinski, M., Bourke, J. P., Clague, J. R., Cobbe, S. M., Connelly, D. T., Griffith, M. J., McKeown, P. P., McLeod, K., Morgan, J. M., Sadoul, N., Chojnowska, L., Huang, C. L.-H., Grace, A. A. (2008). Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J 29: 1653-1661 [Abstract] [Full Text]  
• Pinamonti, B., Di Lenarda, A., Nucifora, G., Gregori, D., Perkan, A., Sinagra, G. (2008). Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study. Eur J Echocardiogr 9: 466-471 [Abstract] [Full Text]  
• Elliott, P. (2008). Relevance of platelet activation in obstructive hypertrophic cardiomyopathy. Heart 94: 688-689 [Full Text]  
• Dimitrow, P P, Undas, A, Bober, M, Tracz, W, Dubiel, J S (2008). Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart 94: e21-e21 [Abstract] [Full Text]  
• Olivotto, I., Girolami, F., Ackerman, M. J., Nistri, S., Bos, J. M., Zachara, E., Ommen, S. R., Theis, J. L., Vaubel, R. A., Re, F., Armentano, C., Poggesi, C., Torricelli, F., Cecchi, F. (2008). Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy. Mayo Clin Proc. 83: 630-638 [Abstract] [Full Text]  
• Mittnacht, A. J., Fanshawe, M., Konstadt, S. (2008). Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery. SEMIN CARDIOTHORAC VASC ANESTH 12: 33-59 [Abstract]  
• Bayrak, F., Kahveci, G., Mutlu, B., Sonmez, K., Degertekin, M. (2008). Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy. Eur J Echocardiogr 9: 278-283 [Abstract] [Full Text]  
• Revera, M., van der Merwe, L., Heradien, M., Goosen, A., Corfield, V. A., Brink, P. A., Moolman-Smook, J. C. (2008). Troponin T and {beta}-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy. Cardiovasc Res 77: 687-694 [Abstract] [Full Text]  
• Hansen, M. W., Merchant, N. (2007). MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances. Am. J. Roentgenol. 189: 1335-1343 [Abstract] [Full Text]  
• ElBardissi, A. W., Dearani, J. A., Nishimura, R. A., Ommen, S. R., Stulak, J. M., Schaff, H. V. (2007). Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy. Mayo Clin Proc. 82: 1516-1522 [Abstract] [Full Text]  
• McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W. K., Dearani, J. A., Schaff, H. V., Tajik, A. J., Gersh, B. J. (2007). Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 28: 2583-2588 [Abstract] [Full Text]  
• Olivotto, I., Ommen, S. R., Maron, M. S., Cecchi, F., Maron, B. J. (2007). Surgical Myectomy Versus Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: Will There Ever Be a Randomized Trial?. J Am Coll Cardiol 50: 831-834 [Abstract] [Full Text]  
• Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., Boriani, G., Estes, N. A. M. III, Favale, S., Piccininno, M., Winters, S. L., Santini, M., Betocchi, S., Arribas, F., Sherrid, M. V., Buja, G., Semsarian, C., Bruzzi, P. (2007). Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JAMA 298: 405-412 [Abstract] [Full Text]  
• Maron, B. J. (2007). Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. Circulation 116: 196-206 [Full Text]  
• Fifer, M. A. (2007). Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy. Circulation 116: 207-216 [Full Text]  
• Petersen, S. E., Jerosch-Herold, M., Hudsmith, L. E., Robson, M. D., Francis, J. M., Doll, H. A., Selvanayagam, J. B., Neubauer, S., Watkins, H. (2007). Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging. Circulation 115: 2418-2425 [Abstract] [Full Text]  
• Barac, I., Upadya, S., Pilchik, R., Winson, G., Passick, M., Chaudhry, F. A., Sherrid, M. V. (2007). Effect of Obstruction on Longitudinal Left Ventricular Shortening in Hypertrophic Cardiomyopathy. J Am Coll Cardiol 49: 1203-1211 [Abstract] [Full Text]  
• Kurisu, S., Inoue, I., Kawagoe, T., Ishihara, M., Shimatani, Y., Nakama, Y., Kagawa, E. (2007). Pressure tracings in obstructive Tako-Tsubo cardiomyopathy. Eur J Heart Fail 9: 317-319 [Abstract] [Full Text]  
• Nagueh, S. F., Mahmarian, J. J. (2006). Noninvasive Cardiac Imaging in Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol 48: 2410-2422 [Abstract] [Full Text]  
• Maron, B. J., Olivotto, I., Maron, M. S. (2006). Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: reply. Eur Heart J 27: 3073-3074 [Full Text]  
• Nishimura, R. A., Ommen, S. R. (2006). Hypertrophic Cardiomyopathy: The Search for Obstruction. Circulation 114: 2200-2202 [Full Text]  
• Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., Maron, B. J. (2006). Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction. Circulation 114: 2232-2239 [Abstract] [Full Text]  
• Knight, C. J (2006). Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.. Heart 92: 1339-1344 [Full Text]  
• Elliott, P. M., Gimeno, J. R., Tome, M. T., Shah, J., Ward, D., Thaman, R., Mogensen, J., McKenna, W. J. (2006). Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27: 1933-1941 [Abstract] [Full Text]  
• Maron, B. J., Olivotto, I., Maron, M. S. (2006). The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?. Eur Heart J 27: 1895-1897 [Full Text]  
• Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey-Bojack, S., Manning, W. J., Udelson, J. E., Maron, B. J. (2006). Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy. Circulation 114: 216-225 [Abstract] [Full Text]  
• Spirito, P., Autore, C. (2006). Management of hypertrophic cardiomyopathy.. BMJ 332: 1251-1255 [Full Text]  
• Olivotto, I., Cecchi, F., Gistri, R., Lorenzoni, R., Chiriatti, G., Girolami, F., Torricelli, F., Camici, P. G. (2006). Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy. J Am Coll Cardiol 47: 1043-1048 [Abstract] [Full Text]  
• Kasikcioglu, E. (2006). The role of echocardiography screening in athletes for cardiovascular disease. Eur J Echocardiogr 7: 182-183 [Full Text]  
• Kido, S., Hasebe, N., Ishii, Y., Kikuchi, K. (2006). Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion of ANP, not BNP, in hypertrophic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 290: H1064-H1070 [Abstract] [Full Text]  
• Minakata, K., Dearani, J. A., O'Leary, P. W., Danielson, G. K. (2005). Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in Pediatric Patients: Early and Late Results. Ann. Thorac. Surg. 80: 1424-1430 [Abstract] [Full Text]  
• Nugent, A. W., Daubeney, P. E.F., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C.W., Weintraub, R. G., for the National Australian Childhood Cardiomyopat, (2005). Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study. Circulation 112: 1332-1338 [Abstract] [Full Text]  
• Rickers, C., Wilke, N. M., Jerosch-Herold, M., Casey, S. A., Panse, P., Panse, N., Weil, J., Zenovich, A. G., Maron, B. J. (2005). Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy. Circulation 112: 855-861 [Abstract] [Full Text]  
• Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., Schaff, H. V., Danielson, G. K., Tajik, A. J., Nishimura, R. A. (2005). Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol 46: 470-476 [Abstract] [Full Text]  
• Watkins, H., McKenna, W. J. (2005). The Prognostic Impact of Septal Myectomy in Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol 46: 477-479 [Full Text]  
• Olivotto, I., Maron, M. S., Adabag, A. S., Casey, S. A., Vargiu, D., Link, M. S., Udelson, J. E., Cecchi, F., Maron, B. J. (2005). Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy. J Am Coll Cardiol 46: 480-487 [Abstract] [Full Text]  
• Yacoub, M. H. (2005). Surgical Versus Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: The Pendulum Swings. Circulation 112: 450-452 [Full Text]  
• Roberts, R., Sigwart, U. (2005). Current Concepts of the Pathogenesis and Treatment of Hypertrophic Cardiomyopathy. Circulation 112: 293-296 [Full Text]  
• Balaram, S. K., Sherrid, M. V., Derose, J. J. Jr., Hillel, Z., Winson, G., Swistel, D. G. (2005). Beyond Extended Myectomy for Hypertrophic Cardiomyopathy: The Resection-Plication-Release (RPR) Repair. Ann. Thorac. Surg. 80: 217-223 [Abstract] [Full Text]  
• Maron, B. J. (2005). Surgery for Hypertrophic Obstructive Cardiomyopathy: Alive and Quite Well. Circulation 111: 2016-2018 [Full Text]  
• Woo, A., Williams, W. G., Choi, R., Wigle, E. D., Rozenblyum, E., Fedwick, K., Siu, S., Ralph-Edwards, A., Rakowski, H. (2005). Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy. Circulation 111: 2033-2041 [Abstract] [Full Text]  
• Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., Maron, B. J. (2005). Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 45: 1251-1258 [Abstract] [Full Text]  
• Autore, C., Bernabo, P., Barilla, C. S., Bruzzi, P., Spirito, P. (2005). The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 45: 1076-1080 [Abstract] [Full Text]  
• Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., Maron, B. J. (2005). Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 45: 697-704 [Abstract] [Full Text]  
• Breithardt, O-A, Beer, G, Stolle, B, Lieder, F, Franke, A, Lawrenz, T, Hanrath, P, Kuhn, H (2005). Mid systolic septal deceleration in hypertrophic cardiomyopathy: clinical value and insights into the pathophysiology of outflow tract obstruction by tissue Doppler echocardiography. Heart 91: 379-380 [Full Text]  
• Ralph-Edwards, A., Woo, A., McCrindle, B. W., Shapero, J. L., Schwartz, L., Rakowski, H., Wigle, E. D., Williams, W. G. (2005). Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J. Thorac. Cardiovasc. Surg. 129: 351-358 [Abstract] [Full Text]  
• Kaufmann, P. A., Camici, P. G. (2005). Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications. JNM 46: 75-88 [Full Text]